CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on July 8, 2013 to all shareholders of record as of June 17, 2013. The Board expects that future cash dividends will be paid on a quarterly basis such that the total annual dividend rate based on the quarterly cash dividend will equal $0.60 per share, which is equivalent to a dividend yield of approximately 2%. Any decision to pay future cash dividends will, however, be subject to Board approval, and will depend on the Company's future earnings, cash flow, financial condition, financial covenants, and other relevant factors.

CONMED Corporation Presents at UBS Global Healthcare Conference, May-22-2013 11:30 AM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Joseph J. Corasanti, Chief Executive Officer, President, Chief Operating Officer and Director.

CONMED Corporation reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported net sales of $187.014 million compared to $194.316 million a year ago. Income from operations was $15.870 million compared to $17.022 million a year ago. Income before income taxes was $14.241 million compared to $15.585 million a year ago. Net income was $10.492 million or $0.37 per diluted share, compared to $9.968 million or $0.35 per diluted share, a year ago. Net cash provided by operating activities was $5.472 million compared to $7.629 million a year ago. Purchases of property, plant and equipment were $4.130 million compared to $6.424 million a year ago. Adjusted income from operations was $20.885 million compared to $20.484 million a year ago. Adjusted diluted earnings per share grew 16.2% to $0.43. EBITDA was $27.481 million against $28.674 million a year ago. Adjusted EBITDA was $32.068 million against $33.319 million a year ago. Adjusted diluted earnings per share grew 4.7% to $0.45. For the full year 2013, the company expects adjusted earnings per share guidance of $1.80 to $1.90. The company considers it’s prudent to reduce the estimated full year sales forecast by $15 million to $770 to $780. The company expects 2013 cash flow from operations to improve in the remaining quarters of 2013 since the pension and incentive compensation payments only affect the first quarter of 2013. The company anticipates a 20% cash tax rate. For the second quarter of 2013, the company anticipates sales will approximate $191 to $196 million and adjusted earnings per share are forecasted to be $0.41 to $0.46.